Company Filing History:
2 out of 63 
2 out of 23 
1 out of 12 
Years Active: 2000-2020
Title: Biography of Magnus Von Knebel-Doeberitz
Introduction: Magnus Von Knebel-Doeberitz is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines.
Latest Patents: Magnus holds a total of 8 patents. His latest patents focus on MSI-specific frameshift peptides (FSP) for the prevention and treatment of cancer. These vaccines are characterized by microsatellite instability (MSI) and are designed to generate humoral and cellular responses against tumor cells. They are particularly useful for the prevention and treatment of colorectal cancer, endometrial cancer, gastric cancer, and small bowel cancer.
Career Highlights: Throughout his career, Magnus has worked with esteemed institutions such as Ruprecht-Karls-Universität Heidelberg and Mtm Laboratories AG. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations: Magnus has collaborated with notable colleagues, including Matthias Kloor and Miriam Reuschenbach. These partnerships have further enriched his research and contributions to the field.
Conclusion: Magnus Von Knebel-Doeberitz continues to be a leading figure in cancer research, with his innovative approaches paving the way for new treatment options. His dedication to improving patient outcomes through scientific advancements is commendable.